Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma, Hepatocellular × netrin-1 inhibitor NP137 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Sorafenib 34 Nivolumab 19 pembrolizumab 15 Bevacizumab 11 Cyclophosphamide 10 durvalumab 9 fludarabine 8 atezolizumab 8 lenvatinib 7 Magnetic Resonance Spectroscopy 7 Ipilimumab 7 Radiotherapy 6 Irinotecan 6 Radiosurgery 5 Oxaliplatin 5 Leucovorin 5 tremelimumab 4 tislelizumab 4 sintilimab 4 cabozantinib 4 budigalimab 4 Specimen Handling 4 Interleukin-2 4 Fluorouracil 4 Doxorubicin 4 Capecitabine 4 toripalimab 3 Sirolimus 3 Melphalan 3 Injections 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05546879 2026-02-10

Liver-NET1

University Hospital, Grenoble

Phase 1 Suspended

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡